Arcutis Biotherapeutics, Inc. Ratios

Ratios Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 79.54%91.63%90.27%
EBT Margin -8,449.76%-434.57%-70.92%
EBIT Margin -8,183.04%-404.49%-65.33%
EBITDA Margin -8,472.30%-437.96%-71.26%
Operating Margin -8,183.04%-404.49%-65.33%
Net Margin -8,449.76%-439.79%-71.25%
FCF Margin -7,000.76%-415.20%-57.14%
Efficiency
Inventory Average 10.32M13.83M
Assets Average 353.21M428.71M395.32M345.13M
Equity Average 284.15M253.63M149.12M123.10M
Invested Capital 270.62M370.03M407.35M290.47M264.74M
Asset Utilization Ratio 0.010.150.57
Leverage & Solvency
Interest Coverage Ratio -19.27-8.11-4.73
Debt to Equity 0.240.942.280.68
Debt Ratio 0.180.440.590.31
Equity Ratio 0.910.730.470.260.45
Times Interest Earned -19.27-8.11-4.73
Valuation
Enterprise Value 1,402.91M656.07M492.14M32.99M1,219.43M
Market Capitalization 1,687.35M1,043.12M901.73M304.85M1,447.39M
Return Ratios
Return on Sales -84.50%-4.40%-0.71%
Return on Capital Employed -0.65%-0.77%-0.69%-0.49%
Return on Assets -0.58%-0.73%-0.66%-0.41%
Return on Equity -0.73%-1.23%-1.76%-1.14%